133 related articles for article (PubMed ID: 8110071)
41. The role of dialyzer membrane flux in bio-incompatibility.
Davenport A
Hemodial Int; 2008 Oct; 12 Suppl 2():S29-33. PubMed ID: 18837767
[TBL] [Abstract][Full Text] [Related]
42. Synthetically modified cellulose: an alternative to synthetic membranes for use in haemodialysis?
Hoenich NA; Woffindin C; Stamp S; Roberts SJ; Turnbull J
Biomaterials; 1997 Oct; 18(19):1299-303. PubMed ID: 9307219
[TBL] [Abstract][Full Text] [Related]
43. Evaluation of a novel vitamin E coated cellulosic membrane hollow fiber dialyzer.
MacGinley R; Westhuyzen J; Saltissi D; Morgan C; Healy H; Thirlwell GK; Disney AP
ASAIO J; 2001; 47(1):66-73. PubMed ID: 11199319
[TBL] [Abstract][Full Text] [Related]
44. Angiogenin: a novel inhibitor of neutrophil lactoferrin release during extracorporeal circulation.
Schmaldienst S; Oberpichler A; Tschesche H; Hörl WH
Kidney Blood Press Res; 2003; 26(2):107-12. PubMed ID: 12771535
[TBL] [Abstract][Full Text] [Related]
45. Reduced cytokine induction and removal of complement products with synthetic hemodialysis membranes.
Schindler R; Ertl T; Beck W; Lepenies J; Boenisch O; Oppermann M; Kaspar E; Frei U
Blood Purif; 2006; 24(2):203-11. PubMed ID: 16373999
[TBL] [Abstract][Full Text] [Related]
46. Comparative study of C5a plasma levels with different hemodialysis membranes using an enzyme-linked immunosorbent assay.
Bingel M; Arndt W; Schulze M; Floege J; Shaldon S; Koch KM; Götze O
Nephron; 1989; 51(3):320-4. PubMed ID: 2918943
[TBL] [Abstract][Full Text] [Related]
47. Evaluation of dialyzers used in shortened dialysis.
Petersen J; Ramsey KD; Kang MS; Yeh IT
ASAIO Trans; 1989; 35(3):338-40. PubMed ID: 2688714
[TBL] [Abstract][Full Text] [Related]
48. [Comparison of the hemodialysis adequacy conducted based on low-flux polysulfone dialyzers and high-flux helixone dialyzers].
Sobaszek-Pitas M; Kopeć J; Krzanowski M; Sułowicz W
Przegl Lek; 2014; 71(7):384-8. PubMed ID: 25338334
[TBL] [Abstract][Full Text] [Related]
49. High-flux synthetic versus cellulosic membranes for beta 2-microglobulin removal during hemodialysis, hemodiafiltration and hemofiltration.
Floege J; Granolleras C; Deschodt G; Heck M; Baudin G; Branger B; Tournier O; Reinhard B; Eisenbach GM; Smeby LC
Nephrol Dial Transplant; 1989; 4(7):653-7. PubMed ID: 2510064
[TBL] [Abstract][Full Text] [Related]
50. Beta 2-microglobulin serum levels during dialysis: effect of cuprophan and serum osmolality changes.
Sulková S; Votruba T; Lapcík O; Válek A
Int J Artif Organs; 1990 Jan; 13(1):22-5. PubMed ID: 2203684
[TBL] [Abstract][Full Text] [Related]
51. Biocompatibility differences with respect to the dialyzer sterilization method.
Müller TF; Seitz M; Eckle I; Lange H; Kolb G
Nephron; 1998; 78(2):139-42. PubMed ID: 9496728
[TBL] [Abstract][Full Text] [Related]
52. Increases in mass transfer-area coefficients and urea Kt/V with increasing dialysate flow rate are greater for high-flux dialyzers.
Leypoldt JK; Cheung AK
Am J Kidney Dis; 2001 Sep; 38(3):575-9. PubMed ID: 11532691
[TBL] [Abstract][Full Text] [Related]
53. Serum beta 2-microglobulin concentration in dialysis patients: importance of intrinsic renal function.
McCarthy JT; Williams AW; Johnson WJ
J Lab Clin Med; 1994 Apr; 123(4):495-505. PubMed ID: 8144998
[TBL] [Abstract][Full Text] [Related]
54. Effect of hemodialysis on leukocyte adhesion receptor expression.
Kaupke CJ; Zhang J; Cesario T; Yousefi S; Akeel N; Vaziri ND
Am J Kidney Dis; 1996 Feb; 27(2):244-52. PubMed ID: 8659501
[TBL] [Abstract][Full Text] [Related]
55. Heterogeneity in gentamicin clearance between high-efficiency hemodialyzers.
Agarwal R; Cronin RE
Am J Kidney Dis; 1994 Jan; 23(1):47-51. PubMed ID: 8285197
[TBL] [Abstract][Full Text] [Related]
56. Leukocyte, platelet and endothelial activation in patients with acute renal failure treated by intermittent hemodialysis.
de Sá HM; Freitas LA; Alves VC; Garção MF; Rosa MA; Marques AA
Am J Nephrol; 2001; 21(4):264-73. PubMed ID: 11509797
[TBL] [Abstract][Full Text] [Related]
57. Biocompatibility aspects of cellophane, cellulose acetate, polyacrylonitrile, polysulfone and polycarbonate hemodialyzers.
Smeby LC; Widerøe TE; Balstad T; Jørstad S
Blood Purif; 1986; 4(1-3):93-101. PubMed ID: 3730167
[TBL] [Abstract][Full Text] [Related]
58. Beta 2-microglobulin kinetics during haemodialysis and haemofiltration.
Flöge J; Granolleras C; Bingel M; Deschodt G; Branger B; Oules R; Koch KM; Shaldon S
Nephrol Dial Transplant; 1987; 1(4):223-8. PubMed ID: 3110678
[TBL] [Abstract][Full Text] [Related]
59. Long-term serum proteomes are quite similar under high- and low-flux hemodialysis treatment.
Hallbauer J; Kreusch S; Klemm A; Wolf G; Rhode H
Proteomics Clin Appl; 2010 Dec; 4(12):953-61. PubMed ID: 21137035
[TBL] [Abstract][Full Text] [Related]
60. Detection of endotoxin antibody in long-term dialysis patients.
Yamagami S; Adachi T; Sugimura T; Wada S; Kishimoto T; Maekawa M; Yoshimura R; Niwa M; Terano Y; Shaldon S
Int J Artif Organs; 1990 Apr; 13(4):205-10. PubMed ID: 2115504
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
